64Cu-PSMA I&T clinical trials

A Phase 3, Multicenter, Open-label Study to Test the Diagnostic Performance of Copper Cu 64 PSMA I&T PET/CT in Staging of Men with Newly Diagnosed Unfavorable Intermediate-risk, High-risk or Very High-risk Prostate Cancer Electing to Undergo Radical Prostatectomy with Pelvic Lymph Node Dissection

This study is looking at a special scan called a PET/CT with copper-64 PSMA. It aims to see how well this scan can find prostate cancer that has spread to nearby lymph nodes in men about to have surgery. This could help doctors better understand the cancer's stage.